Gabriel Tinoco

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial”.

Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial

The Lancet(2024)10.1016/s0140-6736(24)01812-9

N/A

1.4DataRank · unranked

84 citations

Karla V. Ballman, Angela Hong, Scott M. Schuetze, Andrew J. Wagner, Varun Monga +23 more

A bioinformatics tool for identifying intratumoral microbes from the ORIEN dataset

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.24.541982

N/A

0.208DataRank · unranked

3 citations

Anjun Ma, Megan E. McNutt, Rebecca Hoyd, Caroline E. Wheeler, Lary A. Robinson +24 more

Epigenetic Modulation, Intratumoral Microbiome, and Immunity in Early-Onset Colorectal Cancer

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0177

N/A

0.170DataRank · unranked

2 citations

Rebecca Hoyd, Ayse S. Yilmaz, Jiangjiang Zhu, YunZhou Liu, Malvenderjit S. Jagjit Singh +31 more

Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival

Journal of Cancer Research and Clinical Oncology(2022)10.1007/s00432-022-04340-3

N/A

0DataRank · unranked

40 citations

Gabriel Tinoco, Songzhu Zhao, Lai Wei, Andrew Johns, Sandip Pravin Patel +14 more

Sinonasal teratocarcinosarcoma: a therapeutic dilemma

BMJ Case Reports(2022)10.1136/bcr-2022-252429

N/A

0DataRank · unranked

6 citations

Khaled Dibs, Ricardo L Carrau, Lynn Schoenfield, Dukagjin Blakaj, Gabriel Tinoco +1 more

Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03392-9

N/A

0DataRank · unranked

11 citations

Songzhu Zhao, Gabrielle Lopez, Austin Secor, Parthib Das, Nitya Surya +19 more

Emerging Trends in Immunotherapy for Adult Sarcomas

The Oncologist(2023)10.1093/oncolo/oyad052

N/A

0DataRank · unranked

6 citations

Luxi Chen, David A. Liebner, Joal D. Beane, Mark P. Rubinstein, Raphael E. Pollock +3 more

Clinical markers of immunotherapy outcomes in advanced sarcoma

BMC Cancer(2023)10.1186/s12885-023-10758-w

N/A

0DataRank · unranked

4 citations

Dionisia Quiroga, Han Gil Kim, Scott Lenobel, Menglin Xu, Hans Iwenofu +5 more

Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival

Cancer Immunology Immunotherapy(2021)10.1007/s00262-021-03068-2

N/A

0DataRank · unranked

47 citations

Songzhu Zhao, Mingjia Li, Sandip H. Patel, Andrew Johns, Madison Grogan +13 more

The tumor microbiome reacts to hypoxia and can influence response to radiation treatment in colorectal cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.01.555936

N/A

0DataRank · unranked

2 citations

Rebecca Hoyd, McKenzie Kreamer, Caroline E. Wheeler, Dennis J. Grencewicz, Fouad Choueiry +27 more

The Tumor Microbiome Reacts to Hypoxia and Can Influence Response to Radiation Treatment in Colorectal Cancer

Cancer Research Communications(2024)10.1158/2767-9764.crc-23-0367

N/A

0DataRank · unranked

24 citations

Rebecca Hoyd, McKenzie Kreamer, Caroline E. Wheeler, Dennis J. Grencewicz, Fouad Choueiry +27 more

A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3817

N/A

0DataRank · unranked

23 citations

Rachel S. Heise, Kristen Ganjoo, Elizabeth J. Davis, Suzanne George, Melissa Burgess +16 more

Clinical Characteristics, Patterns of Care, and Treatment Outcomes of Radiation-Associated Sarcomas

Cancers(2024)10.3390/cancers16101918

N/A

0DataRank · unranked

3 citations

Han Gil Kim, Menglin Xu, Tyler Roach, David A. Liebner, David J. Konieczkowski +2 more

A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset

Cancer Research Communications(2024)10.1158/2767-9764.crc-23-0213

N/A

0DataRank · unranked

7 citations

Anjun Ma, Yingjie Li, Megan E. McNutt, Shiqi Zhang, Jiangjiang Zhu +27 more

The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.24.542123

N/A

0DataRank · unranked

5 citations

Samuel S. Coleman, Rebecca Hoyd, Louis Denko, Carlos H.F. Chan, Michelle L. Churchman +19 more

Proton pump inhibitor use (PPI) in patients treated with immune checkpoint inhibitors (ICI) for advanced cancer: Survival and prior therapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2633

N/A

0DataRank · unranked

11 citations

Menglin Xu, Sandipkumar Patel, Andrew Johns, Madison Grogan, Mingjia Li +13 more

P10015/SARC033: A phase 2 trial of trametinib in patients with advanced epithelioid hemangioendothelioma (EHE).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11503

N/A

0DataRank · unranked

10 citations

Karla V. Ballman, Kristen Ganjoo, Elizabeth J. Davis, Jeffrey A. Morgan, Gabriel Tinoco +15 more